Oral Session 1-10B Treatment of MM: Immunomodulatory drugs etc

[OS1-10B-6] KRD and KD treatment for relapsed/refractory multiple myeloma in Kansai Myeloma Forum study

Yoshiyuki Onda¹, Junya Kanda¹, Hitomi Kaneko², Hirohiko Shibayama³, Yuji Shimura⁴, Kensuke Ohta⁵, Hirokazu Tanaka⁶, Shin-Ichi Fuchida⁷, Aya Nakaya⁸, Nobuhiko Uoshima⁹, Satoru Kosugi¹⁰, Mitsuhiro Matsuda¹¹, Yoko Adachi¹², Hideo Yagi¹³, Hitoji Uchiyama¹⁴, Maki Shindo¹, Kazunori Imada², Masayuki Hino¹⁵, Shosaku Nomura¹⁶, Chihiro Shimazaki⁷, Junya Kuroda⁴, Yuzuru Kanakura³, Akifumi Takaori-Kondo¹, Itaru Matsumura⁶ (1.Hematol. and Oncol., Kyoto Univ., Kyoto, Japan, 2.Hematol., Japanese Red Cross Osaka Hospital, Osaka, Japan, 3.Hematol. and Oncol., Osaka Univ.,Osaka, Japan, 4.Hematol. and Oncol., Kyoto Prefectural Univ. of Medicine, Kyoto, Japan, 5.Hematol., Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 6.Hematol. and Rheumatol., Kinki Univ., Osaka, Japan, 7.Hematol., JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 8.Hematol., Kansai Medical Univ. Medical Center, Osaka, Japan, 9.Hematol., Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 10.Internal Medicine (Hematol.), Toyonaka Municipal Hospital, Osaka, Japan, 11.Hematol., PL General Hospital, Osaka, Japan, 12.Internal Medicine, JCHO Kobe Central Hospital, Hyogo, Japan, 13.Hematol. and Oncol., Nara Prefecture General Medical Center, Nara, Japan, 14.Hematol., Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 15.Hematol., Osaka City Univ. Osaka, Japan, 16.First Department of Internal Medicine, Kansai Medical Univ.,Osaka, Japan)